$16.54
-0.29-1.72%
At close: Nov 11, 4:00 PM EST
$16.50
-0.33-1.96%
Pre-Market: 7:52 AM EST
NeoGenomics Inc
NEONASDAQ
NeoGenomics rose 65.2% from $10.01 to $16.54, ahead of the S&P 500's +12.7%. Its worst day was Oct 6 (−13.7%), and its low came Mar 27 at $7.19.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.06 beat the $0.01 estimate on $190.2M revenue (est. $188.4M); FY revenue guidance of $793.0M–$801.0M against the $768.3M consensus.
+0.5% · S&P 500 +0.2%
Story events cover the past 12 months · Times ET
NeoGenomics closed at its lowest level of the year, 28.2% below where the year started.
−7.3% · S&P 500 −1.7%
EPS of $0.01 beat the $-0.02 estimate on $186.7M revenue (est. $184.5M); FY revenue guidance of $797.0M–$803.0M against the $796.6M consensus.
−0.7% · S&P 500 0.0%
NeoGenomics shares rose 11.5%, while the S&P 500 rose 0.4%.
+11.5% · S&P 500 +0.4%
NeoGenomics shares rose 12.5%, while the S&P 500 fell 0.0%.
+12.5% · S&P 500 0.0%
EPS of $0.05 beat the $0.01 estimate on $202.0M revenue (est. $197.0M); FY revenue guidance of $802.0M–$806.0M against the $800.3M consensus.
+14.0%, the year's best day · S&P 500 −1.5%
NeoGenomics closed at its highest level of the year, 98.9% above where the year started.
+0.1% · S&P 500 +0.1%
NeoGenomics shares fell 13.7%, while the S&P 500 rose 0.5%.
−13.7%, the year's worst day · S&P 500 +0.5%
EPS of $0.07 beat the $0.04 estimate on $209.3M revenue (est. $207.4M); FY revenue guidance of $807.0M–$809.0M against the $805.3M consensus.
−0.3% · S&P 500 −0.4%
Where it ended: a close of $16.54 on Nov 12, 2026. Up next: Q4 2026 earnings on Feb 16, 2027 (EPS est. $0.07, revenue est. $210.5M).
Nothing in the past 12 months.
All NEO dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NEO and SPY from Benzinga historical bars. Not investment advice.
